Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2000
12/28/2000WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000WO2000056353A3 A uro-genital condition treatment system
12/28/2000WO2000056301A3 Treatment of posttraumatic stress disorder, obsessive-compulsive disorder and related neuropsychiatric disorders
12/28/2000WO2000054780A3 Corticosteroid formulation
12/28/2000WO2000054754A3 Composition comprising isoquercetin and ascorbic acid in a sustained release form
12/28/2000WO2000051593A3 Oral drug delivery system
12/28/2000WO2000045845A3 Liposome composition and method for administration of a radiosensitizer
12/28/2000WO2000043034A3 Monodisperse hexameric acylated insulin analog formulations
12/28/2000WO2000030667A3 Compositions and methods using lactadherin or variants thereof
12/28/2000DE19958228A1 Paroxetinmethansulfonat enthaltendes Arzneimittel Paroxetine-containing medicines
12/28/2000DE19929197A1 Transdermalsysteme zur Abgabe von 5-HT3-Rezeptor-Antagonisten und ihre Verwendung zur antiemitischen Behandlung Transdermal systems for the delivery of 5-HT3 receptor antagonists and their use for the treatment antiemitischen
12/28/2000DE19929104A1 Vector complex, useful for gene therapy of e.g. tumors, comprises nucleic acid, cationic carrier, charged polymer and targeting ligand
12/28/2000DE19922662C1 Transdermales therapeutisches System (TTS) Tolterodin enthaltend Transdermal therapeutic system (TTS) containing tolterodine
12/28/2000DE19920908A1 Particulate solid drug carrier, providing retarded release and high bioavailability, comprising lipid-drug conjugate, e.g. tributyrin as source of cell differentiation inhibitor butyric acid
12/28/2000CA2778826A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
12/28/2000CA2392210A1 Degradable cross-linking agents and cross-linked network polymers formed therewith
12/28/2000CA2377517A1 Amphiphilic drug-oligomer conjugates with hydrolyzable lipophile components and methods for making and using the same
12/28/2000CA2377371A1 Enhanced wound coverage to enhance wound healing
12/28/2000CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000CA2376829A1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a
12/28/2000CA2376155A1 Pharmaceutical composition for oral use
12/28/2000CA2375508A1 Methods and products for manipulating uncoupling protein expression
12/28/2000CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
12/28/2000CA2375358A1 Antibiotic agents
12/28/2000CA2375207A1 Peptide having preptin functionality
12/28/2000CA2374760A1 Quickly disintegrating solid preparations
12/28/2000CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/28/2000CA2371931A1 Steroid solution aerosol products with enhanced chemical stability
12/28/2000CA2371924A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/27/2000EP1063241A1 Pharmaceutical preparations comprising thioctic acid or dihydrolipoic acid in the form of inclusion compounds with cyclodextrins oder cyclodextrin derivatives and in the form of granulates, chewing-or effervescent tablets
12/27/2000EP1063234A2 Hydrophobic taxane derivates
12/27/2000EP1062955A1 Medicinal compositions adhering to stomach/duodenum
12/27/2000EP1062952A1 Bubbling enteric coated preparations
12/27/2000EP1062945A1 Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
12/27/2000EP1062879A1 Aqueous solution for the parenteral nutrition
12/27/2000EP1062328A1 Suicide gene therapy system for the treatment of brain tumours
12/27/2000EP1062274A1 Polyvinyl alcohol compositions
12/27/2000EP1062223A1 Composition containing a precursor capable of being hydrolysed by glucocerebrosidase
12/27/2000EP1062032A1 Method and device for capsulating microbial, plant and animal cells or biological and chemical substances
12/27/2000EP1061987A1 Drug delivery system
12/27/2000EP1061961A1 Apparatuses and processes for whole-body hyperthermia
12/27/2000EP1061951A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin
12/27/2000EP1061948A1 Sustained-release preparation of physiologically active polypeptide and production thereof
12/27/2000EP1061947A1 Stabilized aqueous peptide solutions
12/27/2000EP1061942A1 Topical composition containing human epidermal growth factor
12/27/2000EP1061938A1 Oral compositions at low dosage of cytotoxic proteins
12/27/2000EP1061929A1 Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
12/27/2000EP1061920A1 Pharmaceutical formulation comprising a 2[[(2-pyridinyl)methyl]sulfinyl]benzimidazole having anti-ulcer activity and a process for the preparation of such formulation
12/27/2000EP1061918A1 Controlled release composition of (1-azabicyclo(2.2.2)oct-3-yl)acetonitrile monohydrochloride
12/27/2000EP1061906A1 Monolithic tablet for controlled drug release
12/27/2000EP1061905A2 Methods and compositions for detection and diagnosis of infectious diseases
12/27/2000EP1061904A1 Nanoparticles, method for producing nanoparticles and use of the same
12/27/2000EP1061903A1 Delivery system to modulate immune response
12/27/2000EP1061902A1 Colonic delivery of protein or peptide compositions
12/27/2000EP1061901A1 Nicotine inhaler
12/27/2000EP1061900A1 Dermal compositions
12/27/2000EP1061873A1 Use of corneal hardening agents in enzyme orthokeratology
12/27/2000EP1061803A1 Novel compositions of eprosartan
12/27/2000EP1061802A1 Topical carbamazepine formulations and methods of use
12/27/2000EP1061799A1 Tissue paper having antimicrobial skin lotion
12/27/2000EP1021180A4 Mixed cyanoacrylate ester compositions
12/27/2000EP0873099B1 Pack for the nose
12/27/2000EP0833619B1 Controlled release of drugs delivered by sublingual or buccal administration
12/27/2000EP0759746B1 A medicated wipe
12/27/2000EP0627924B1 Composition comprising coagulation factor viii formulation, process for its preparation and use of a surfactant as stabilizer
12/27/2000EP0619730B1 Composition of antineoplastic agents incorporated in micelles
12/27/2000CN2411806Y Medicinal magnet pain relieving plaster
12/27/2000CN2411786Y Medical plaster
12/27/2000CN1278175A Compositions of lipid lowering agents
12/27/2000CN1278174A Nicotine compositions and method for formulation thereof
12/27/2000CN1278173A Skin penetration enhancing components
12/27/2000CN1278165A Extended release formulation contg. venlafaxin
12/27/2000CN1278164A Solid state solutions and dispersions of poorly water soluble drugs
12/27/2000CN1278163A Microcrystalline cellulose/alginate pharmaceutical suspensions
12/27/2000CN1278162A Sustained release eyedrops
12/27/2000CN1278158A Synergistic analgestic combination of opioid analgsic and cyclooxygenase-2
12/27/2000CN1277872A Process for extracting linoleic acid and producing soft capsule contg. linoleic acid
12/27/2000CN1277845A Method for preparing soft capsule of forest frog oil
12/27/2000CN1277840A Tanshinone solid disperser and its prepn. method
12/27/2000CN1277801A Method for preparing suspended pesticides concentrates
12/27/2000CN1059835C Plaster used for anti-cancer and relieving pain
12/27/2000CN1059832C Medical cigarette for treating tooth ache and its preparing method
12/27/2000CN1059822C Buccal tablet of Radix Rhodiolae preparation and preparing method thereof
12/27/2000CN1059813C Cardio- and cerebro-angiopathy curing drop pellet and its preparation method
12/27/2000CN1059807C Spur pain-removing plaster
12/27/2000CN1059804C Adhesive plaster for wound and preparation process thereof
12/26/2000US6167313 Targeted hysteresis hyperthermia as a method for treating diseased tissue
12/26/2000US6166173 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same
12/26/2000US6166092 Carrier for uniform distribution
12/26/2000US6166087 Immunosuppresants, antiinflammatory agents, antitumor agents;applying to mucous membranes
12/26/2000US6166083 Suckable flurbiprofen lozenges for treatment of sore throat
12/26/2000US6166081 Methods and apparatus for treatment of Parkinson's disease
12/26/2000US6166075 A 3,4-diphenylbicyclo(4.3.0)nonyl compound
12/26/2000US6166062 Pharmaceutical compositions containing phospholipase inhibitor
12/26/2000US6166061 Methods and formulations for modulating the human sexual response
12/26/2000US6166044 Colonic delivery of nicotine to treat inflammatory bowel disease
12/26/2000US6166043 Insulin sensitivity enhancer such as pioglitazone in combination with a biguanide such as metformin
12/26/2000US6166042 Pharmaceutical composition
12/26/2000US6166029 Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
12/26/2000US6166025 A stable, aqueous drug formulation for treating migraine
1 ... 2428 2429 2430 2431 2432 2433 2434 2435 2436 2437 2438 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 ... 2991